论文信息 - Bi38-3 is a novel CD38/CD3 bispecific T-cell engager with low toxicity for the treatment of multiple myeloma - 字舞流文

Bi38-3 is a novel CD38/CD3 bispecific T-cell engager with low toxicity for the treatment of multiple myeloma

B. Arnulf | J. Bories | J. Fermand | A. Bensussan | Carolina Martínez-Cingolani | A. Talbot | Nathalie Roders | Elisabeth Nelson | C. Choisy | Maxime Fayon | Audrey Abecassis